Literature DB >> 17077311

Design of phosphorylated dendritic architectures to promote human monocyte activation.

Mary Poupot1, Laurent Griffe, Patrice Marchand, Alexandrine Maraval, Olivier Rolland, Ludovic Martinet, Fatima-Ezzahra L'Faqihi-Olive, Cédric-Olivier Turrin, Anne-Marie Caminade, Jean-Jacques Fournié, Jean-Pierre Majoral, Rémy Poupot.   

Abstract

As first defensive line, monocytes are a pivotal cell population of innate immunity. Monocyte activation can be relevant to a range of immune conditions and responses. Here we present new insights into the activation of monocytes by a series of phosphonic acid-terminated, phosphorus-containing dendrimers. Various dendritic or subdendritic structures were synthesized and tested, revealing the basic structural requirements for monocyte activation. We showed that multivalent character and phosphonic acid capping of dendrimers are crucial for monocyte targeting and activation. Confocal videomicroscopy showed that a fluorescein-tagged dendrimer binds to isolated monocytes and gets internalized within a few seconds. We also found that dendrimers follow the phagolysosomial route during internalization by monocytes. Finally, we performed fluorescence resonance energy transfer (FRET) experiments between a specifically designed fluorescent dendrimer and phycoerythrin-coupled antibodies. We showed that the typical innate Toll-like receptor (TLR)-2 is clearly involved, but not alone, in the sensing of dendrimers by monocytes. In conclusion, phosphorus-containing dendrimers appear as precisely tunable nanobiotools able to target and activate human innate immunity and thus prove to be good candidates to develop new drugs for immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077311     DOI: 10.1096/fj.06-5742com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  Are plasma mineral levels related to antibody response to influenza vaccination in older adults?

Authors:  Ata Murat Kaynar; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Krissy K Moehling; Michael Susick; Veli Bakalov; Bruce R Pitt; Daniel J Bain; Ted M Ross; Sean G Saul; Mahlon Raymund; Richard K Zimmerman
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

2.  The key role of the scaffold on the efficiency of dendrimer nanodrugs.

Authors:  Anne-Marie Caminade; Séverine Fruchon; Cédric-Olivier Turrin; Mary Poupot; Armelle Ouali; Alexandrine Maraval; Matteo Garzoni; Marek Maly; Victor Furer; Valeri Kovalenko; Jean-Pierre Majoral; Giovanni M Pavan; Rémy Poupot
Journal:  Nat Commun       Date:  2015-07-14       Impact factor: 14.919

3.  Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier.

Authors:  D Shcharbin; V Dzmitruk; A Shakhbazau; N Goncharova; I Seviaryn; S Kosmacheva; M Potapnev; E Pedziwiatr-Werbicka; M Bryszewska; M Talabaev; A Chernov; V Kulchitsky; A-M Caminade; J-P Majoral
Journal:  Pharmaceutics       Date:  2011-08-05       Impact factor: 6.321

4.  An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.

Authors:  Ranime Jebbawi; Abdelouahd Oukhrib; Emily Clement; Muriel Blanzat; Cédric-Olivier Turrin; Anne-Marie Caminade; Eric Lacoste; Séverine Fruchon; Rémy Poupot
Journal:  Biomolecules       Date:  2020-06-23

5.  Complexing Methylene Blue with Phosphorus Dendrimers to Increase Photodynamic Activity.

Authors:  Monika Dabrzalska; Anna Janaszewska; Maria Zablocka; Serge Mignani; Jean Pierre Majoral; Barbara Klajnert-Maculewicz
Journal:  Molecules       Date:  2017-02-23       Impact factor: 4.411

6.  Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.

Authors:  Damien Portevin; Mary Poupot; Olivier Rolland; Cédric-Olivier Turrin; Jean-Jacques Fournié; Jean-Pierre Majoral; Anne-Marie Caminade; Remy Poupot
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

Review 7.  AB5 Derivatives of Cyclotriphosphazene for the Synthesis of Dendrons and Their Applications.

Authors:  Artem Zibarov; Abdelouahd Oukhrib; Julien Aujard Catot; Cédric-Olivier Turrin; Anne-Marie Caminade
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

8.  Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.

Authors:  Yannick Degboé; Séverine Fruchon; Michel Baron; Delphine Nigon; Cédric Olivier Turrin; Anne-Marie Caminade; Rémy Poupot; Alain Cantagrel; Jean-Luc Davignon
Journal:  Arthritis Res Ther       Date:  2014-04-18       Impact factor: 5.156

9.  An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.

Authors:  Séverine Fruchon; Anne-Marie Caminade; Claire Abadie; Jean-Luc Davignon; Jean-Marc Combette; Cédric-Olivier Turrin; Rémy Poupot
Journal:  Molecules       Date:  2013-08-05       Impact factor: 4.411

10.  Phosphorus dendrimers as carriers of siRNA--characterisation of dendriplexes.

Authors:  Malgorzata Ferenc; Elzbieta Pedziwiatr-Werbicka; Katarzyna E Nowak; Barbara Klajnert; Jean-Pierre Majoral; Maria Bryszewska
Journal:  Molecules       Date:  2013-04-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.